Wolters Kluwer Logo Wolters Kluwer Logo
Open search
Search suggestion
Open suggestion box
Search suggestion
log in button See related products
arrow down
Kluwer Patent Blog
Search filters
Clear all
GENERAL PREFERENCES
Search only titles
Jurisdiction
Category
Tags
Contributor
Date
From
To
End date must be later than the start date.

Search Results for:

117 results available

search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: Koninklijke Philips N.V. vs. Wiko SAS, Netherlands
July 31, 2019

The holder of a standard essential patent (SEP) should first notify the alleged infringer of the SEP, following which the alleged infringer should inform the patent holder of its willingness to take…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: Eli Lilly and Company vs. Fresenius Kabi Nederland B.V., Netherlands
July 18, 2019

The scope of a patent is to be interpreted according to Art. 69 EPC and the Protocol. If the literal text is limiting, the question is how the skilled person would understand this limitation. If the…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: HE Licenties B.V. vs VG Colours B.V., Netherlands
July 09, 2019

A patent that is limited during the course of the proceedings (even after the pleadings) is held to have been so limited ab initio if the limitation is duly registered. When a European patent is…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: Accord Healthcare Ltd. vs. Shire-NPS Pharmaceuticals Inc., Netherlands
June 27, 2019

The Court held that a selection invention is inventive if the compound of the selection offers surprisingly advantageous or improved properties over the prior art compounds. These properties should…

  • Read more
search-result-placeholder-16-9.jpg
Rik Lambers (Brinkhof)
The Pemetrexed Pendulum Swings Back
June 21, 2019

Pemetrexed, yet again: last Wednesday the District Court of The Hague, swimming against the current and after a deep dive in the prosecution file, decided that Fresenius did not infringe Eli Lilly's…

  • Read more
search-result-placeholder-16-9.jpg
Kluwer Patent blogger
'Debate in The Netherlands about medicine prices is too polarized'
June 13, 2019

The focus in The Netherlands on the option of compounding medicines as a means to circumvent the use of (expensive) authorised medicinal products of pharmaceutical companies and to pressurize them…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: Mobile Sanitary Solutions B.V. vs. TWT Verhuur B.V., Netherlands
June 13, 2019

Although at first instance the patent was found to lack inventive step without using the problem-and-solution approach, the use of the PSA by the Court of Appeal did not make a difference to the…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: AcelorMittal France vs. Tata Steel IJmuiden B.V., Netherlands
June 04, 2019

The Court held that the CJEU decision in the Bericarp case, where it was decided that for invalidity procedures no reimbursement of full litigation costs applies, did apply to invalidity proceedings…

  • Read more
search-result-placeholder-16-9.jpg
Bart van Wezenbeek (Hoffmann Eitle)
Patent case: G.D. Searle v. Sandoz B.V., Netherlands
April 09, 2019

The Court concluded that the compound darunavir was not protected by a patent within the sense of Art. 3 of the SPC directive because, following the CJEU decision in Teva v Gilead, it is necessary…

  • Read more
search-result-placeholder-16-9.jpg
Rik Lambers (Brinkhof)
Dutch Discovery: to beer or not to beer
March 20, 2019

… that is the question in recent ‘Dutch discovery’ proceedings in a patent dispute between beer giants Anheuser-Busch Inbev (‘ABI’) and Heineken. Well, sort of: the legal question was if ABI would be…

  • Read more
41 - 50 of 117 results
  • 1
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 12
  • About Kluwer Patent Blog
  • Contact Us
  • Wolters Kluwer: IP Law
    Wolters Kluwer: IP Law
  • Wolters Kluwer on X
    Wolters Kluwer: X
  • KLI YouTube
    YouTube
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies
  • User Agreement and Disclaimer

© 2025 Wolters Kluwer N.V. and/or its subsidiaries. All rights reserved.